Simone Song
Fondateur chez ORI Capital Investment Advisory Hong Kong Ltd.
Fortune : 11 M $ au 31/05/2024
Provenance du réseau au premier degré de Simone Song
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.
13
| Holding Company | Pharmaceuticals: Major | 13 |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom.
12
| Subsidiary | Biotechnology | 12 |
ORI Capital Investment Advisory Hong Kong Ltd.
 ORI Capital Investment Advisory Hong Kong Ltd. Investment ManagersFinance ORI Capital Investment Advisory Hong Kong Ltd (ORI Capital) is a venture capital firm in Hong Kong. The firm was founded by Simone Song in 2015. The firm is headquartered in Hong Kong.
9
| Private Company | Investment Managers | 9 |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Simone Song via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | President Chairman Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Founder Founder Chief Executive Officer Director/Board Member Director/Board Member | |
| TRISALUS LIFE SCIENCES, INC. | Medical Specialties | Director/Board Member Chairman Director of Finance/CFO Chief Executive Officer Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
Orchard Therapeutics North America
 Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | Biotechnology | Director/Board Member President Chief Executive Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| KURA ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Caduceus Medical Holdings LLC
 Caduceus Medical Holdings LLC Pharmaceuticals: MajorHealth Technology Caduceus Medical Holdings LLC operates as an investment and holding company which focuses on healthcare services and products. The company was founded by Pedro Vergne-Marini, Jerry M. Huffman and Mats Wahlström in 2010 and is headquartered in Dallas, TX. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Baylor College of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| LEXICON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Doctorate Degree | |
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Breakout Investment Partners LLC | Chairman Chairman | ||
| University of Michigan | College/University | Undergraduate Degree Corporate Officer/Principal | |
KMG Capital Partners LLC
 KMG Capital Partners LLC Investment ManagersFinance KMG Capital Partners LLC (KMG Capital Partners) is a venture capital/private equity firm founded in 2012. The firm is headquartered in Denver, Colorado. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
| University of Hong Kong | College/University | Undergraduate Degree Graduate Degree | |
Healthgrades Operating Co., Inc.
 Healthgrades Operating Co., Inc. Internet Software/ServicesTechnology Services Healthgrades Operating Co., Inc. engages in the provision of health information across digital platforms. It helps to compare providers, review hospital quality, make appointments with clinical providers, prepare for their healthcare appointments, and research comprehensive health and wellness information. The company was founded by Kerry R. Hicks and David G. Hicks in 1998 and is headquartered in Denver, CO. | Internet Software/Services | Founder Director/Board Member | |
| The Chinese University of Hong Kong | College/University | Graduate Degree Graduate Degree | |
Empirican Group, Inc.
 Empirican Group, Inc. Packaged SoftwareTechnology Services Empirican Group, Inc. operates a practice-based clinical research site network. It offers Circuit Clinical that streamlines the process while removing cost for physicians in order to bring new medical solutions to patients. The company was founded by Irfan Khan in 2014 and is headquartered in Buffalo, NY. | Packaged Software | Director/Board Member Director/Board Member | |
Sieger Healthcare Acquisition Corp.
 Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Sieger Healthcare Acquisition Corp. is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on May 18, 2021, and is headquartered in Singapore. | Financial Conglomerates | Director/Board Member | |
| GENERATION BIO CO. | Pharmaceuticals: Major | Director/Board Member | |
| ExpressionEdits Ltd. | Miscellaneous Commercial Services | Founder | |
| Urumqi Jintiantu Equity Investment Partnership LP | Corporate Officer/Principal | ||
Ipsen Bioinnovation Ltd.
 Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
| VERNALIS | Pharmaceuticals: Major | Corporate Officer/Principal | |
Datamonitor Ltd.
 Datamonitor Ltd. Investment ManagersFinance Datamonitor Ltd. is a UK-based investment research firm which was founded by Michael Danson in 1988. The firm is headquartered in London and they are a subsidiary of Informa Group Ltd., which is owned by Informa Plc (LON: INF). Datamonitor provides market research and analysis products and services for the financial services, healthcare, energy, and automotive industrial sectors. | Investment Managers | Corporate Officer/Principal | |
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Pharmaceuticals: Major | Founder | |
| DIMENSION THERAPEUTICS INC | Biotechnology | Founder | |
| Sichuan University | College/University | Undergraduate Degree | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member | |
Shenzhen Duopule Industrial Development Co., Ltd.
 Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Wholesale Distributors | Director/Board Member | |
| Shenzhen Techdow Pharmaceutical Co., Ltd. | Director/Board Member | ||
| UW Graduate School | College/University | Doctorate Degree | |
PetMedix Ltd.
 PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Founder | |
| UW Medicine | College/University | Graduate Degree | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Director/Board Member | |
| Translational Research In Oncology | Corporate Officer/Principal | ||
| CG ONCOLOGY, INC. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 30 |
| Royaume-Uni | 12 |
| Chine | 6 |
| Hong Kong | 3 |
| Îles Cayman | 2 |
Sectorielle
| Health Technology | 27 |
| Consumer Services | 10 |
| Finance | 4 |
| Technology Services | 3 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 222 |
| Corporate Officer/Principal | 75 |
| Independent Dir/Board Member | 62 |
| Chief Executive Officer | 51 |
| Chairman | 46 |
Relations les plus connectées
| Insiders | |
|---|---|
| Alf Gunnar Martin Nicklasson | 31 |
| Charles Rowland | 25 |
| Mats Wahlström | 25 |
| James Geraghty | 25 |
| Timothy James Rink | 23 |
| Sean Murphy | 22 |
| Benjamin Auspitz | 20 |
| Mary Szela | 19 |
| Anil Singhal | 18 |
| Marc Dunoyer | 16 |
| Gene R. McGrevin | 15 |
| Diane Parks | 14 |
| Kerry Hicks | 14 |
| James Mulé | 14 |
| Mark Rothera | 14 |
- Bourse
- Insiders
- Simone Song
- Connexions Sociétés
